Diverse characteristics of111In labelled anti-CEA monoclonal antibodies for tumour immunoscintigraphy: Radiolabelling, biodistribution and imaging studies in mice with human tumour xenografts

1987 ◽  
Vol 12 (10) ◽  
pp. 515-521 ◽  
Author(s):  
Malcolm V. Pimm ◽  
Alan C. Perkins ◽  
Robert W. Baldwin
Keyword(s):  
Monoclonal Antibodies ◽  
Imaging Studies ◽  
Human Tumour ◽  
Human Tumour Xenografts ◽  
Tumour Xenografts

BNP7787, a novel protector against platinum-related toxicities, does not affect the efficacy of cisplatin or carboplatin in human tumour xenografts

2002 ◽  
Vol 38 (8) ◽  
pp. 1148-1156 ◽  
Author(s):  
E Boven ◽  
M Verschraagen ◽  
T.M Hulscher ◽  
C.A.M Erkelens ◽  
F.H Hausheer ◽  
...  
Keyword(s):  
Human Tumour ◽  
Human Tumour Xenografts ◽  
Tumour Xenografts

scholarly journals High antitumour activity of ET743 against human tumour xenografts from melanoma, non-small-cell lung and ovarian cancer

1999 ◽  
Vol 10 (10) ◽  
pp. 1233-1240 ◽  
Author(s):  
H.R. Hendriks ◽  
H.H. Fiebig ◽  
R. Giavazzi ◽  
S.P. Langdon ◽  
J.M. Jimeno ◽  
...  
Keyword(s):  
Ovarian Cancer ◽  
Antitumour Activity ◽  
Small Cell ◽  
Small Cell Lung ◽  
Human Tumour ◽  
Human Tumour Xenografts ◽  
Tumour Xenografts

Does Ro 03–8799 Concentration in Human Tumour Xenografts Predict Radiosensitization? Comparison with SR-2508

1990 ◽  
pp. 165-172
Author(s):  
Marcelle Guichard ◽  
Alphonse Taghian ◽  
Francoise Lespinasse ◽  
Edmond Philippe Malaise
Keyword(s):  
Human Tumour ◽  
Human Tumour Xenografts ◽  
Tumour Xenografts
Sign in / Sign up

Export Citation Format

Share Document